Winton Group’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLD
BBA
KCM
Winton Group's PRLD Position: Q3 2026 in Review
Winton Group opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 19,500 shares worth $76.2K. The stake represents ﹤0.01% of the portfolio and ranks #1050 among its holdings.
90 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.
- Winton Group held 19,500 shares of Prelude Therapeutics worth $76.2K as of Q3 2026.
- Prelude Therapeutics was a new Winton Group position in Q3 2026.
- Prelude Therapeutics made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1050 holding.
- 90 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.
Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.